episode-header-image

Aug 2021

18m 34s

Coronapod: COVID boosters amidst global ...

SPRINGER NATURE LIMITED

About this episode

Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile with limited vaccine supplies - billions around the world still have no access to vaccines at all. In this episode of Coronapod we discuss the science of boosters, the stark reality of vaccine disparity and what this means for the future of the pandemic.

News: COVID boosters for wealthy nations spark outrage

News feature: COVID vaccine boosters: the most important questions

Coronapod: the inequality at the heart of the pandemic

Coronapod: the biomarker that could change COVID vaccines

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.

Up next

Fusion energy gets a boost from cold fusion chemistry

00:46 Electrochemical fusionResearchers have used electrochemistry to increase the rates of nuclear fusion reactions in a desktop reactor. Fusion energy promises abundant clean energy, but fusion events are rare, hindering progress. Now, inspired by the controversial claim of col ... Show More

Controversial climate report from Trump team galvanizes scientists into action

In this Podcast Extra, we discuss a report released by the US Department of Energy, which concluded that global warming is “less damaging economically than commonly believed”. However, many researchers say that the report misrepresents decades of climate science.We discuss how sc ... Show More

Sun-powered flyers could explore the mysterious mesosphere

00:46 Tiny solar flyerResearchers have used a phenomenon known as thermal transpiration to create a solar-powered flying device that can stay aloft without any moving parts. The diminutive device, just one centimetre across, consists of two thin, perforated membranes that allow a ... Show More

Recommended Episodes

The Evidence: When will the pandemic end?

Everybody hopes that the new super-charged Omicron variant of coronavirus will be less severe, but even if it is, it’s spreading so fast and infecting so many people, health services around the world could still buckle under the strain.Two years into the pandemic, Claudia Hammond ... Show More

The Race for a Vaccine

Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how the ... Show More

Covipod #9 : Le vaccin, moins efficace chez certaines personnes

Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autour d ... Show More

The State of Vaccinations

The United States has never undertaken a vaccination campaign of the scale and speed of the Covid-19 program. Despite a few glitches, the country appears to be on track to offer shots to all adults who want one by May 1.We look at the ups and downs in the American vaccination cam ... Show More

The deadly consequences of an uneven vaccine rollout

US President Joe Biden has promised every American adult they will be eligible for a COVID vaccination by April 19th. But what about the rest of the world? Only 0.01% of all vaccines distributed have gone to the developing world and now Kenya is being a hit by its 3rd wave of the ... Show More

Vaccine hesitancy, the next pandemic hurdle

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More

The Jab: Will there be enough vaccines?

It is one thing to design and test covid-19 vaccines. It is another to make them at sufficient scale to generate the billions of doses needed to vaccinate the world’s population. How are the vaccines produced, why is production so variable and will it meet demand this year? We sp ... Show More

How close are we to a vaccine for Covid-19?

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ... Show More

Listen to millions of songs and podcasts on Anghami